help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on March 16, 2006, doi:10.1165/rcmb.2005-0239OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0239OCv1
35/2/175    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, B. B.
Right arrow Articles by Toews, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, B. B.
Right arrow Articles by Toews, G. B.
American Journal of Respiratory Cell and Molecular Biology. Vol. 35, pp. 175-181, 2006
© 2006 American Thoracic Society
DOI: 10.1165/rcmb.2005-0239OC

The Role of CCL12 in the Recruitment of Fibrocytes and Lung Fibrosis

Bethany B. Moore, Lynne Murray, Anuk Das, Carol A. Wilke, Amy B. Herrygers and Galen B. Toews

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan; and Department of Immunobiology, Centocor Inc., Radnor, Pennsylvania

Correspondence and requests for reprints should be addressed to Bethany B. Moore, University of Michigan, Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, 6301 MSRB III, 1150 W. Medical Center Dr., Ann Arbor, MI 48109-0642. E-mail: Bmoore{at}umich.edu

We have previously shown that mice that are genetically deficient in the CCR2 gene (CCR2–/– mice) are protected from fluorescein isothiocyanate (FITC)-induced lung fibrosis. Protection from fibrosis correlated with impaired recruitment of fibrocytes (bone marrow–derived cells, which share both leukocyte and mesenchymal markers). There are three ligands for CCR2 in the mouse: CCL2, CCL7, and CCL12. CCL2 and CCL12 are both elevated in the lung after FITC injury, but with different kinetics. CCL2 is maximal at Day 1 and absent by Day 7 after FITC. In contrast, CCL12 peaks at Day 3, but remains elevated through Day 21 after FITC. We now demonstrate that while CCR2–/– mice are protected from FITC-induced fibrosis, CCL2–/– mice are not. CCL2–/– mice are able to recruit fibrocytes to FITC-injured airspaces, unlike CCR2–/– mice. Adoptive transfer of CCR2-expressing fibrocytes augments FITC-induced fibrosis in both wild-type and CCR2–/– mice, suggesting that these cells play a pathogenic role in the disease process. Both CCL2 and CCL12 are chemotactic for fibrocytes. However, neutralization of CCL12 in wild-type mice significantly protects from FITC-induced fibrosis, whereas neutralization of CCL2 was less effective. Thus, CCL12 is likely the CCR2 ligand responsible for driving fibroproliferation in the mouse. As murine CCL12 is homologous to human CCL2, we suggest that the pathobiology of murine CCL12 in fibroproliferation may correlate to human CCL2 biology.

Key Words: chemokines • fibrocytes • fibrosis • lung




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
H. Tanjore, X. C. Xu, V. V. Polosukhin, A. L. Degryse, B. Li, W. Han, T. P. Sherrill, D. Plieth, E. G. Neilson, T. S. Blackwell, et al.
Contribution of Epithelial-derived Fibroblasts to Bleomycin-induced Lung Fibrosis
Am. J. Respir. Crit. Care Med., October 1, 2009; 180(7): 657 - 665.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. B. Moore
Fibrocytes as Potential Biomarkers in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 524 - 525.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Moeller, S. E. Gilpin, K. Ask, G. Cox, D. Cook, J. Gauldie, P. J. Margetts, L. Farkas, J. Dobranowski, C. Boylan, et al.
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 588 - 594.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
D. Sun, C. O. Martinez, O. Ochoa, L. Ruiz-Willhite, J. R. Bonilla, V. E. Centonze, L. L. Waite, J. E. Michalek, L. M. McManus, and P. K. Shireman
Bone marrow-derived cell regulation of skeletal muscle regeneration
FASEB J, February 1, 2009; 23(2): 382 - 395.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
A.-M. Pulichino, I-M. Wang, A. Caron, J. Mortimer, A. Auger, Y. Boie, J. A. Elias, A. Kartono, L. Xu, J. Menetski, et al.
Identification of Transforming Growth Factor {beta}1-Driven Genetic Programs of Acute Lung Fibrosis
Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 324 - 336.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
E. S. Muise, B. Azzolina, D. W. Kuo, M. El-Sherbeini, Y. Tan, X. Yuan, J. Mu, J. R. Thompson, J. P. Berger, and K. K. Wong
Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor {gamma} and Altered Metabolic States
Mol. Pharmacol., August 1, 2008; 74(2): 403 - 412.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Proceedings of the ATS, July 15, 2008; 5(5): 637 - 667.
[Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
D. D. Shao, R. Suresh, V. Vakil, R. H. Gomer, and D. Pilling
Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation
J. Leukoc. Biol., June 1, 2008; 83(6): 1323 - 1333.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
G. J. Laurent, R. J. McAnulty, M. Hill, and R. Chambers
Escape from the Matrix: Multiple Mechanisms for Fibroblast Activation in Pulmonary Fibrosis
Proceedings of the ATS, April 15, 2008; 5(3): 311 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. R. McMillan, B. B. Moore, J. B. Weinberg, K. M. Vannella, W. B. Fields, P. J. Christensen, L. F. van Dyk, and G. B. Toews
Exacerbation of Established Pulmonary Fibrosis in a Murine Model by Gammaherpesvirus
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 771 - 780.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. B. Moore and C. M. Hogaboam
Murine models of pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L152 - L160.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. M. Vannella, T. R. McMillan, R. P. Charbeneau, C. A. Wilke, P. E. Thomas, G. B. Toews, M. Peters-Golden, and B. B. Moore
Cysteinyl Leukotrienes Are Autocrine and Paracrine Regulators of Fibrocyte Function
J. Immunol., December 1, 2007; 179(11): 7883 - 7890.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
J. S. Hagood and M. A. Olman
Muscle Fatigue: MK2 Signaling and Myofibroblast Differentiation
Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 503 - 506.
[Full Text] [PDF]

Home page
 ChestHome page
C. J. Scotton and R. C. Chambers
Molecular Targets in Pulmonary Fibrosis: The Myofibroblast in Focus
Chest, October 1, 2007; 132(4): 1311 - 1321.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. R. Collard, B. B. Moore, K. R. Flaherty, K. K. Brown, R. J. Kaner, T. E. King Jr., J. A. Lasky, J. E. Loyd, I. Noth, M. A. Olman, et al.
Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 636 - 643.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Pilling, D. Roife, M. Wang, S. D. Ronkainen, J. R. Crawford, E. L. Travis, and R. H. Gomer
Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P
J. Immunol., September 15, 2007; 179(6): 4035 - 4044.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
B. N. Gomperts and R. M. Strieter
Fibrocytes in lung disease
J. Leukoc. Biol., September 1, 2007; 82(3): 449 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
R. Jain, P. W. Shaul, Z. Borok, and B. C. Willis
Endothelin-1 Induces Alveolar Epithelial-Mesenchymal Transition through Endothelin Type A Receptor-Mediated Production of TGF-beta1
Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 38 - 47.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. P. Baran, J. M. Opalek, S. McMaken, C. A. Newland, J. M. O'Brien Jr., M. G. Hunter, B. D. Bringardner, M. M. Monick, D. R. Brigstock, P. C. Stromberg, et al.
Important Roles for Macrophage Colony-stimulating Factor, CC Chemokine Ligand 2, and Mononuclear Phagocytes in the Pathogenesis of Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 78 - 89.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
J. Gauldie, M. Kolb, K. Ask, G. Martin, P. Bonniaud, and D. Warburton
Smad3 Signaling Involved in Pulmonary Fibrosis and Emphysema
Proceedings of the ATS, November 1, 2006; 3(8): 696 - 702.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2006 American Thoracic Society. 		  New Orleans Int'l Conf